{
  "DOI": "10.1038/sj.ejhg.5201884",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/sj.ejhg.5201884",
  "alternative-id": [
    "BF5201884"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Liu",
      "given": "Baorui",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Wei",
      "given": "Jia",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zou",
      "given": "Zhengyun",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Qian",
      "given": "Xiaoping",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Nakamura",
      "given": "Takahiro",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zhang",
      "given": "Wei",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ding",
      "given": "Yitao",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Feng",
      "given": "Jifeng",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Yu",
      "given": "Lixia",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2007,
        6,
        27
      ]
    ],
    "date-time": "2007-06-27T05:23:57Z",
    "timestamp": 1182921837000
  },
  "deposited": {
    "date-parts": [
      [
        2024,
        2,
        15
      ]
    ],
    "date-time": "2024-02-15T13:50:20Z",
    "timestamp": 1708005020000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        2,
        15
      ]
    ],
    "date-time": "2024-02-15T14:11:59Z",
    "timestamp": 1708006319716
  },
  "is-referenced-by-count": 41,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "10",
  "issued": {
    "date-parts": [
      [
        2007,
        6,
        27
      ]
    ]
  },
  "journal-issue": {
    "issue": "10",
    "published-print": {
      "date-parts": [
        [
          2007,
          10
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2007,
            6,
            27
          ]
        ],
        "date-time": "2007-06-27T00:00:00Z",
        "timestamp": 1182902400000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/5201884.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/5201884",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/5201884.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1049-1053",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2007,
        6,
        27
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2007,
        6,
        27
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2007,
        10
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.3322/canjclin.55.2.74",
      "author": "DM Parkin",
      "doi-asserted-by": "publisher",
      "first-page": "74",
      "journal-title": "CA Cancer J Clin",
      "key": "BF5201884_CR1",
      "unstructured": "Parkin DM, Bray F, Ferlay J, Pisani P : Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74–108.",
      "volume": "55",
      "year": "2005"
    },
    {
      "DOI": "10.1186/1471-2407-6-274",
      "author": "S Sadighi",
      "doi-asserted-by": "publisher",
      "first-page": "274",
      "journal-title": "BMC Cancer",
      "key": "BF5201884_CR2",
      "unstructured": "Sadighi S, Mohagheghi MA, Montazeri A, Sadighi Z : Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF). BMC Cancer 2006; 6: 274.",
      "volume": "6",
      "year": "2006"
    },
    {
      "DOI": "10.1038/sj.bjc.6602572",
      "author": "K Sumpter",
      "doi-asserted-by": "publisher",
      "first-page": "1976",
      "journal-title": "Br J Cancer",
      "key": "BF5201884_CR3",
      "unstructured": "Sumpter K, Harper-Wynne C, Cunningham D et al: Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF. Br J Cancer 2005; 92: 1976–1983.",
      "volume": "92",
      "year": "2005"
    },
    {
      "DOI": "10.1200/JCO.2006.06.8429",
      "author": "E Van Cutsem",
      "doi-asserted-by": "publisher",
      "first-page": "4991",
      "journal-title": "J Clin Oncol",
      "key": "BF5201884_CR4",
      "unstructured": "Van Cutsem E, Moiseyenko VM, Tjulandin S et al: Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol 2006; 24: 4991–4997.",
      "volume": "24",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.coph.2006.01.011",
      "author": "R Rosell",
      "doi-asserted-by": "publisher",
      "first-page": "323",
      "journal-title": "Curr Opin Pharmacol",
      "key": "BF5201884_CR5",
      "unstructured": "Rosell R, Cecere F, Santarpia M, Reguart N, Taron M : Predicting the outcome of chemotherapy for lung cancer. Curr Opin Pharmacol 2006; 6: 323–331.",
      "volume": "6",
      "year": "2006"
    },
    {
      "DOI": "10.1056/NEJMoa060570",
      "author": "KA Olaussen",
      "doi-asserted-by": "publisher",
      "first-page": "983",
      "journal-title": "N Engl J Med",
      "key": "BF5201884_CR6",
      "unstructured": "Olaussen KA, Dunant A, Fouret P et al: DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med 2006; 355: 983–991.",
      "volume": "355",
      "year": "2006"
    },
    {
      "DOI": "10.1038/sj.bjc.6601487",
      "author": "S Marsh",
      "doi-asserted-by": "publisher",
      "first-page": "8",
      "journal-title": "Br J Cancer",
      "key": "BF5201884_CR7",
      "unstructured": "Marsh S, McLeod HL : Cancer pharmacogenetics. Br J Cancer 2004; 90: 8–11.",
      "volume": "90",
      "year": "2004"
    },
    {
      "DOI": "10.1200/JCO.2004.08.067",
      "author": "S Gurubhagavatula",
      "doi-asserted-by": "publisher",
      "first-page": "2594",
      "journal-title": "J Clin Oncol",
      "key": "BF5201884_CR8",
      "unstructured": "Gurubhagavatula S, Liu G, Park S et al: XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy. J Clin Oncol 2004; 22: 2594–2601.",
      "volume": "22",
      "year": "2004"
    },
    {
      "DOI": "10.1186/1476-4598-4-18",
      "author": "DA Weaver",
      "doi-asserted-by": "publisher",
      "first-page": "18",
      "journal-title": "Mol Cancer",
      "key": "BF5201884_CR9",
      "unstructured": "Weaver DA, Crawford EL, Warner KA, Elkhairi F, Khuder SA, Willey JC : ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines. Mol Cancer 2005; 4: 18.",
      "volume": "4",
      "year": "2005"
    },
    {
      "DOI": "10.3109/10409239509083491",
      "author": "JD Hayes",
      "doi-asserted-by": "publisher",
      "first-page": "445",
      "journal-title": "Crit Rev Biochem Mol Biol",
      "key": "BF5201884_CR10",
      "unstructured": "Hayes JD, Pulford DJ : The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995; 30: 445–600.",
      "volume": "30",
      "year": "1995"
    },
    {
      "DOI": "10.1093/carcin/19.2.275",
      "author": "MA Watson",
      "doi-asserted-by": "publisher",
      "first-page": "275",
      "journal-title": "Carcinogenesis",
      "key": "BF5201884_CR11",
      "unstructured": "Watson MA, Stewart RK, Smith GB, Massey TE, Bell DA : Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 1998; 19: 275–280.",
      "volume": "19",
      "year": "1998"
    },
    {
      "DOI": "10.1093/nar/gki543",
      "author": "R Brem",
      "doi-asserted-by": "publisher",
      "first-page": "2512",
      "journal-title": "Nucleic Acids Res",
      "key": "BF5201884_CR12",
      "unstructured": "Brem R, Hall J : XRCC1 is required for DNA single-strand break repair in human cells. Nucleic Acids Res 2005; 33: 2512–2520.",
      "volume": "33",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.dnarep.2006.10.002",
      "author": "ZK Nazarkina",
      "doi-asserted-by": "publisher",
      "first-page": "254",
      "journal-title": "DNA Repair (Amst)",
      "key": "BF5201884_CR13",
      "unstructured": "Nazarkina ZK, Khodyreva SN, Marsin S, Lavrik OI, Radicella JP : XRCC1 interactions with base excision repair DNA intermediates. DNA Repair (Amst) 2007; 6: 254–264.",
      "volume": "6",
      "year": "2007"
    },
    {
      "DOI": "10.1158/1055-9965.801.13.5",
      "author": "S Savas",
      "doi-asserted-by": "crossref",
      "first-page": "801",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "BF5201884_CR14",
      "unstructured": "Savas S, Kim DY, Ahmad MF, Shariff M, Ozcelik H : Identifying functional genetic variants in DNA repair pathway using protein conservation analysis. Cancer Epidemiol Biomarkers Prev 2004; 13: 801–807.",
      "volume": "13",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.lungcan.2006.08.009",
      "author": "C Kiyohara",
      "doi-asserted-by": "publisher",
      "first-page": "267",
      "journal-title": "Lung Cancer",
      "key": "BF5201884_CR15",
      "unstructured": "Kiyohara C, Takayama K, Nakanishi Y : Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. Lung Cancer 2006; 54: 267–283.",
      "volume": "54",
      "year": "2006"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-06-0381",
      "author": "MC Stern",
      "doi-asserted-by": "publisher",
      "first-page": "2384",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "BF5201884_CR16",
      "unstructured": "Stern MC, Siegmund KD, Conti DV, Corral R, Haile RW : XRCC1, XRCC3, and XPD polymorphisms as modifiers of the effect of smoking and alcohol on colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2006; 15: 2384–2390.",
      "volume": "15",
      "year": "2006"
    },
    {
      "DOI": "10.1093/carcin/bgi084",
      "author": "WY Huang",
      "doi-asserted-by": "publisher",
      "first-page": "1354",
      "journal-title": "Carcinogenesis",
      "key": "BF5201884_CR17",
      "unstructured": "Huang WY, Chow WH, Rothman N et al: Selected DNA repair polymorphisms and gastric cancer in Poland. Carcinogenesis 2005; 26: 1354–1359.",
      "volume": "26",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.ejca.2006.11.005",
      "author": "H Hirata",
      "doi-asserted-by": "publisher",
      "first-page": "231",
      "journal-title": "Eur J Cancer",
      "key": "BF5201884_CR18",
      "unstructured": "Hirata H, Hinoda Y, Tanaka Y et al: Polymorphisms of DNA repair genes are risk factors for prostate cancer. Eur J Cancer 2007; 43: 231–237.",
      "volume": "43",
      "year": "2007"
    },
    {
      "DOI": "10.1245/s10434-006-9112-y",
      "author": "KW Suh",
      "doi-asserted-by": "publisher",
      "first-page": "1379",
      "journal-title": "Ann Surg Oncol",
      "key": "BF5201884_CR19",
      "unstructured": "Suh KW, Kim JH, Kim do Y, Kim YB, Lee C, Choi S : Which gene is a dominant predictor of response during FOLFOX chemotherapy for the treatment of metastatic colorectal cancer, the MTHFR or XRCC1 gene? Ann Surg Oncol 2006; 13: 1379–1385.",
      "volume": "13",
      "year": "2006"
    },
    {
      "DOI": "10.1093/annonc/mdj135",
      "author": "R de las Penas",
      "doi-asserted-by": "publisher",
      "first-page": "668",
      "journal-title": "Ann Oncol",
      "key": "BF5201884_CR20",
      "unstructured": "de las Penas R, Sanchez-Ronco M, Alberola V et al: Spanish Lung Cancer Group. Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients. Ann Oncol 2006; 17: 668–675.",
      "volume": "17",
      "year": "2006"
    },
    {
      "DOI": "10.1200/JCO.2006.05.9923",
      "author": "MA Bewick",
      "doi-asserted-by": "publisher",
      "first-page": "5645",
      "journal-title": "J Clin Oncol",
      "key": "BF5201884_CR21",
      "unstructured": "Bewick MA, Conlon MS, Lafrenie RM : Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer. J Clin Oncol 2006; 24: 5645–5651.",
      "volume": "24",
      "year": "2006"
    },
    {
      "DOI": "10.1200/JCO.2005.03.6640",
      "author": "X Wu",
      "doi-asserted-by": "publisher",
      "first-page": "3789",
      "journal-title": "J Clin Oncol",
      "key": "BF5201884_CR22",
      "unstructured": "Wu X, Gu J, Wu TT et al: Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. J Clin Oncol 2006; 4: 3789–3798.",
      "volume": "4",
      "year": "2006"
    },
    {
      "DOI": "10.1200/JCO.2005.04.8322",
      "author": "A Ruzzo",
      "doi-asserted-by": "publisher",
      "first-page": "1883",
      "journal-title": "J Clin Oncol",
      "key": "BF5201884_CR23",
      "unstructured": "Ruzzo A, Graziano F, Kawakami K et al: Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy. J Clin Oncol 2006; 24: 1883–1891.",
      "volume": "24",
      "year": "2006"
    },
    {
      "author": "DJ Park",
      "first-page": "8654",
      "journal-title": "Cancer Res",
      "key": "BF5201884_CR24",
      "unstructured": "Park DJ, Stoehlmacher J, Zhang W, Tsao-Wei DD, Groshen S, Lenz HJ : A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer. Cancer Res 2001; 61: 8654–8658.",
      "volume": "61",
      "year": "2001"
    },
    {
      "DOI": "10.1016/j.lungcan.2003.11.019",
      "author": "JS Ryu",
      "doi-asserted-by": "publisher",
      "first-page": "311",
      "journal-title": "Lung Cancer",
      "key": "BF5201884_CR25",
      "unstructured": "Ryu JS, Hong YC, Han HS et al: Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy. Lung Cancer 2004; 44: 311–316.",
      "volume": "44",
      "year": "2004"
    },
    {
      "DOI": "10.1093/annonc/mdh319",
      "author": "D Isla",
      "doi-asserted-by": "publisher",
      "first-page": "1194",
      "journal-title": "Ann Oncol",
      "key": "BF5201884_CR26",
      "unstructured": "Isla D, Sarries C, Rosell R et al: Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer. Ann Oncol 2004; 15: 1194–1203.",
      "volume": "15",
      "year": "2004"
    },
    {
      "DOI": "10.1038/sj.bjc.6601975",
      "author": "J Stoehlmacher",
      "doi-asserted-by": "publisher",
      "first-page": "344",
      "journal-title": "Br J Cancer",
      "key": "BF5201884_CR27",
      "unstructured": "Stoehlmacher J, Park DJ, Zhang W et al: A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer. Br J Cancer 2004; 91: 344–354.",
      "volume": "91",
      "year": "2004"
    },
    {
      "DOI": "10.1016/S0169-5002(02)00184-8",
      "author": "D Xing",
      "doi-asserted-by": "publisher",
      "first-page": "123",
      "journal-title": "Lung Cancer",
      "key": "BF5201884_CR28",
      "unstructured": "Xing D, Tan W, Wei Q, Lin D : Polymorphisms of the DNA repair gene XPD and risk of lung cancer in a Chinese population. Lung Cancer 2002; 38: 123–129.",
      "volume": "38",
      "year": "2002"
    },
    {
      "DOI": "10.1002/cncr.20729",
      "author": "G Yang",
      "doi-asserted-by": "publisher",
      "first-page": "52",
      "journal-title": "Cancer",
      "key": "BF5201884_CR29",
      "unstructured": "Yang G, Shu XO, Ruan ZX et al: Genetic polymorphisms in glutathione-S-transferase genes (GSTM1, GSTT1, GSTP1) and survival after chemotherapy for invasive breast carcinoma. Cancer 2005; 103: 52–58.",
      "volume": "103",
      "year": "2005"
    },
    {
      "DOI": "10.1038/sj.bjc.6602891",
      "author": "E Goekkurt",
      "doi-asserted-by": "publisher",
      "first-page": "281",
      "journal-title": "Br J Cancer",
      "key": "BF5201884_CR30",
      "unstructured": "Goekkurt E, Hoehn S, Wolschke C et al: Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS)--novel predictors for response and survival in gastric cancer patients. Br J Cancer 2006; 94: 281–286.",
      "volume": "94",
      "year": "2006"
    },
    {
      "DOI": "10.1093/jnci/94.12.936",
      "author": "J Stoehlmacher",
      "doi-asserted-by": "publisher",
      "first-page": "936",
      "journal-title": "J Natl Cancer Inst",
      "key": "BF5201884_CR31",
      "unstructured": "Stoehlmacher J, Park DJ, Zhang W et al: Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. J Natl Cancer Inst 2002; 94: 936–942.",
      "volume": "94",
      "year": "2002"
    },
    {
      "DOI": "10.1038/nrd1691",
      "author": "D Wang",
      "doi-asserted-by": "publisher",
      "first-page": "307",
      "journal-title": "Nat Rev Drug Discov",
      "key": "BF5201884_CR32",
      "unstructured": "Wang D, Lippard SJ : Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 2005; 4: 307–320.",
      "volume": "4",
      "year": "2005"
    },
    {
      "author": "M Nishiyama",
      "first-page": "2620",
      "journal-title": "Clin Cancer Res",
      "key": "BF5201884_CR33",
      "unstructured": "Nishiyama M, Yamamoto W, Park JS et al: Low-dose cisplatin and 5-fluorouracil in combination can repress increased gene expression of cellular resistance determinants to themselves. Clin Cancer Res 1999; 5: 2620–2628.",
      "volume": "5",
      "year": "1999"
    },
    {
      "author": "M Zhan",
      "first-page": "336",
      "journal-title": "Chin Med J (Engl)",
      "key": "BF5201884_CR34",
      "unstructured": "Zhan M, Liu X : Schedule-dependent reversion of cisplatin resistance by 5-fluorouracil in a cisplatin-resistant human lung adenocarcinoma cell line A549DDP. Chin Med J (Engl) 1999; 112: 336–339.",
      "volume": "112",
      "year": "1999"
    }
  ],
  "reference-count": 34,
  "references-count": 34,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/5201884"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Polymorphism of XRCC1 predicts overall survival of gastric cancer patients receiving oxaliplatin-based chemotherapy in Chinese population"
  ],
  "type": "journal-article",
  "volume": "15"
}